Mesoblast Ltd
F:LWB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Mesoblast Ltd
F:LWB
|
AU |
|
G
|
Genworth Financial Inc
BMV:GNW
|
US |
|
T
|
Tokyo Electron Ltd
OTC:TOELF
|
JP |
|
A
|
ALK-Abello A/S
LSE:0OIR
|
DK |
|
K
|
Kinross Gold Corp
F:KIN2
|
CA |
|
R
|
Rollatainers Ltd
BSE:502448
|
IN |
|
S
|
Spie SA
SWB:4SP
|
FR |
|
Brookfield Corp
F:K7X
|
CA |
|
C
|
Cencora Inc
SWB:ABG
|
US |
|
G
|
General Motors Co
F:8GM
|
US |
|
M
|
Magna International Inc
XMUN:MGA
|
CA |
|
I
|
IDEXX Laboratories Inc
SWB:IX1
|
US |
|
C
|
Consolidated Water Co Ltd
F:CW2
|
KY |
|
P
|
Pool Corp
F:SP1
|
US |
|
First Republic Bank
OTC:FRCB
|
US |
|
M
|
Myriad Genetics Inc
XBER:MYD
|
US |
|
S
|
Sinopharm Group Co Ltd
XMUN:X2S
|
CN |
|
C
|
City Developments Ltd
SWB:CDE
|
SG |
|
De' Longhi SpA
F:DLN
|
IT |
Bankruptcy Probability
Mesoblast Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Mesoblast Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
Mesoblast Ltd
ASX:MSB
|
2.5B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
444.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
195.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
156.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
126.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
65.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
50.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Mesoblast Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Mesoblast Ltd has total debt of 66m USD. This includes both short-term (0 USD) and long-term (66m USD) debt.
You can find a full breakdown on its Balance Sheet.
